Saturday, June 1, 2013

MeRS & H7N9 Updates from the WHO - Not Good Folks

Besides Yellow Fever in Ethiopia and Ebola in the Congo deadly diseases are surfacing in extremely populated regions - China, Middle-East and Africa. To add intensity to the global chaos we have had a record number of Earthquakes, Tornadoes, Volcanos, Fire, Drought and Celestial strangers.

The Frankenstein Family is busy at work trying very hard to rid this planet of the meandering sheep. Food for thought - weather manipulation and virus creations are the ultimate eugenics tools. Compared to war it is extremely cost effective and the virus does not suffer from PTSD.

One severely infected individual from any one of these regions, arriving in North America, could have a more catastrophic impact than a nuclear dirty bomb.

31 May 2013 - The Ministry of Health in Saudi Arabia has notified WHO of an additional laboratory-confirmed case with Middle East respiratory syndrome coronavirus (MERS-CoV).

The patient is a 61-year-old man with underlying medical conditions who became ill on 20 May 2013. The patient is from Al-Ahsa. Additionally, three patients earlier reported from Al-Ahsa have died.

The government is continuing to investigate the outbreaks in the country.
Globally, from September 2012 to date, WHO has been informed of a total of 50 laboratory-confirmed cases of infection with MERS-CoV, including 30 deaths.

WHO has received reports of laboratory-confirmed cases originating in the following countries in the Middle East to date: Jordan, Qatar, Saudi Arabia, and the United Arab Emirates (UAE). France, Germany, Tunisia and the United Kingdom also reported laboratory-confirmed cases; they were either transferred there for care of the disease or returned from the Middle East and subsequently became ill. In France, Tunisia and the United Kingdom, there has been limited local transmission among patients who had not been to the Middle East but had been in close contact with the laboratory-confirmed or probable cases.

Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.

Health care providers are advised to maintain vigilance. Recent travellers returning from the Middle East who develop SARI should be tested for MERS-CoV as advised in the current surveillance recommendations. Specimens from patients’ lower respiratory tracts should be obtained for diagnosis where possible. Clinicians are reminded that MERS-CoV infection should be considered even with atypical signs and symptoms, such as diarrhoea, in patients who are immunocompromised.

Health care facilities are reminded of the importance of systematic implementation of infection prevention and control (IPC). Health care facilities that provide care for patients suspected or confirmed with MERS-CoV infection should take appropriate measures to decrease the risk of transmission of the virus to other patients, health care workers and visitors.

All Member States are reminded to promptly assess and notify WHO of any new case of infection with MERS-CoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course. Investigation into the source of exposure should promptly be initiated to identify the mode of exposure, so that further transmission of the virus can be prevented.

WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.

WHO continues to closely monitor the situation.

Human infection with avian influenza A(H7N9) virus – update

29 May 2013 - The National Health and Family Planning Commission, China notified WHO of an additional laboratory confirmed case of human infection with Avian Influenza A(H7N9) virus.

The patient is a six-year-old boy reported from Beijing who became ill on 21 May 2013 and is in stable condition.

To date, WHO has been informed of a total of 132 laboratory-confirmed cases, including 37 deaths.

Authorities in affected locations continue to maintain surveillance, epidemiological investigations, close contact tracing, clinical management, laboratory testing and sharing of samples as well as prevention and control measures. City and provincial governments have started to normalize their emergency operations into their routine surveillance and response activities.

So far, there is no evidence of sustained human-to-human transmission.
Until the source of infection has been identified and controlled, it is expected that there will be further cases of human infection with the virus.

WHO does not advise special screening at points of entry with regard to this event, nor does it currently recommend any travel or trade restrictions.

WHO continues to work with Member States and international partners to monitor the situation. WHO will provide updates as the situation evolves.
Thank you,
Joseph Pede

No comments: